Clinical Trials for Paratek Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Paratek Pharmaceuticals

Clinical Trials (2)

NCT05753215
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
PHASE2Recruiting
180 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05217537
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
PHASE1Recruiting
40 participants
Started: Apr 6, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor9 locations